| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 06/14/2000 | CN1053375C Chinese medicine preparation for hepatosis |
| 06/14/2000 | CN1053362C Baicaoshengshou oral liquid and its prep. |
| 06/14/2000 | CN1053354C Medicinal powder for poultry |
| 06/14/2000 | CN1053353C Instant medicine powder for toothache and its prep. |
| 06/14/2000 | CN1053347C Chinese pill for treatment of hepatic disease |
| 06/14/2000 | CN1053340C Medicine with function of regulating gastrointestinal tract capable of resisting fatigue |
| 06/14/2000 | CN1053320C Use of micellar casein of butter milk |
| 06/13/2000 | US6075033 Anthranilic acid diamides derivatives, their preparation and pharmaceutical use as anti-gastrin agents |
| 06/13/2000 | US6075006 For treatment of arthritis, asthma, inflammation, tumoral growth, gastro intestinal hypermotility, huntington disease, neuritis, neuralgia, migraine, hypertension, incontinence of urine, urticaria, symptoms of the carcinoid syndrome |
| 06/13/2000 | US6074852 Producing mannose-terminated protein by culturing host cell transformed with gene from e1 or e2 region, causing expression but inhibiting sialylation, isolating glycoprotein using mannose-binding protein |
| 06/13/2000 | US6074846 Hepatitis C virus asialoglycoproteins |
| 06/13/2000 | US6074839 Transforming growth factor αHI |
| 06/13/2000 | US6074648 Galenic preparation for prevention and treatment of hepatocarcinoma |
| 06/08/2000 | WO2000032766A1 Human vanilloid receptors and their uses |
| 06/08/2000 | WO2000032634A1 Humanized antibodies to gamma-interferon |
| 06/08/2000 | WO2000032600A1 8-azabicyclo[3.2.1]oct-2-ene and -octane derivatives |
| 06/08/2000 | WO2000032589A1 Eletriptan hydrobromide monohydrate |
| 06/08/2000 | WO2000032584A2 Nonsteroidal antiinflammatories |
| 06/08/2000 | WO2000032582A1 Benzamide derivatives and their use as apob-100 secretion inhibitors |
| 06/08/2000 | WO2000032575A1 β-ALANINE DERIVATIVES AS α4 INTEGRIN INHIBITORS |
| 06/08/2000 | WO2000032570A1 Hydrazine derivatives |
| 06/08/2000 | WO2000032558A1 Therapeutic product and its use |
| 06/08/2000 | WO2000032217A1 Small peptides and methods for treatment of asthma and inflammation |
| 06/08/2000 | WO2000032215A1 PGC-1, A NOVEL BROWN FAT PPARη COACTIVATOR |
| 06/08/2000 | WO2000032214A1 Preventives for hepatopathy |
| 06/08/2000 | WO2000032192A1 Drugs |
| 06/08/2000 | WO2000032189A1 Celecoxib compositions |
| 06/08/2000 | WO2000032188A2 Use of amtolmetin guacyl as an antiinflammatory drug |
| 06/08/2000 | WO2000032160A1 Methods of reducing the astringency of stannous in dentifrice compositions |
| 06/08/2000 | WO2000015659A3 Stomach polypeptide zsig28 |
| 06/08/2000 | WO2000015245A3 Stable liquid formulations of botulinum toxin |
| 06/08/2000 | WO2000013531A3 Composition comprising a viscosity modulating polymer material and its use |
| 06/08/2000 | WO2000012481A3 Indazole derivatives with 5-ht2 receptor activity________________ |
| 06/08/2000 | WO2000011191A3 Tpl-2/cot kinase and methods of use |
| 06/08/2000 | DE19915560C1 Preparation of digestion promoting drug comprises obtaining distillate obtained in production of herbal drugs by extracting plants and evaporating obtained tincture |
| 06/08/2000 | DE19855566A1 Use of a medicament comprising e.g. heparinoids for treating toothache and dental inflammation and suppuration by application to the skin |
| 06/08/2000 | CA2634658A1 Use of amtolmetin guacyl for the production of anti-inflammatory drugs for intestinal inflammations |
| 06/08/2000 | CA2353550A1 Small peptides and methods for treatment of asthma and inflammation |
| 06/08/2000 | CA2353394A1 Benzamide derivatives and their use as apob-100 secretion inhibitors |
| 06/08/2000 | CA2352612A1 Pharmaceuticals |
| 06/08/2000 | CA2352525A1 Agent protective against hepatopathy |
| 06/08/2000 | CA2352367A1 Nonsteroidal antiinflammatories |
| 06/08/2000 | CA2351321A1 Hydrazine derivatives |
| 06/08/2000 | CA2350635A1 Therapeutic product and its use |
| 06/08/2000 | CA2347701A1 .beta.-alanine derivatives as .alpha.4 integrin inhibitors |
| 06/08/2000 | CA2342621A1 8-azabicyclo[3.2.1]oct-2-ene and -octane derivatives |
| 06/07/2000 | EP1005868A1 Use of alpha interferon and ribavirin in the manufacture of a medicament for combination therapy for chronic hepatitis C infection |
| 06/07/2000 | EP1005867A2 Botulinum toxins for modulating cholinergic controlled secretions |
| 06/07/2000 | EP1005480A1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases |
| 06/07/2000 | EP1005446A1 N-aroylphenylalanine derivatives |
| 06/07/2000 | EP1005445A1 N-alkanoylphenylalanine derivatives |
| 06/07/2000 | EP1005366A1 Functional dna clone for hepatitis c virus (hcv) and uses thereof |
| 06/07/2000 | EP1005353A1 Pharmaceutical preparation comprising lactobacillus casei rhamnosus |
| 06/07/2000 | EP1005341A1 Il-8 receptor antagonists |
| 06/07/2000 | EP1005327A1 Targeted liposomal constructs for diagnostic and therapeutic uses |
| 06/07/2000 | EP0840606B1 Di- and trivalent small molecule selectin inhibitors |
| 06/07/2000 | EP0773025B1 New stable galenic formulations containing an acid-labile benzimidazol compound, and production process |
| 06/07/2000 | CN1255363A Medicinal ice for oral cavity and preparing process thereof |
| 06/07/2000 | CN1255338A Medicine for treating anorexia |
| 06/07/2000 | CN1255335A Cathartic |
| 06/07/2000 | CN1053115C Medicine for acute diarrhea of baby and prepn. thereof |
| 06/07/2000 | CN1053114C Medicine for curing bilestone and biliary calculus |
| 06/07/2000 | CN1053112C Medicine for treating nephropathy and gastropathy |
| 06/07/2000 | CN1053111C Chinese medical composite prepn. with such functions as dispelling toxicity, detoxicating, recuperating, and face nursing |
| 06/07/2000 | CN1053110C Prescription of Chinese medicine for treating cholecystitis, cholelithiasis, hepatitis and cholehepatocirrhosis |
| 06/06/2000 | US6071968 Phenylenediamine derivative radical scavenger, brain-infarction depressant, and brain-edema depressant |
| 06/06/2000 | US6071961 For treating gastritis caused by caphylobacteria by administeing microbiocide comprising aliphatic or aromatic fatty acid, hydrotope and compatible acid |
| 06/06/2000 | US6071953 For treating or preventing cardiovascular or gastrointestinal disorders, potassium channel modulators |
| 06/06/2000 | US6071948 Treatment of diseases caused by excessive blood vessel growth |
| 06/06/2000 | US6071938 Benzopyrans |
| 06/06/2000 | US6071927 Tachykinnin antagonists for the treatment or prevention of pain, inflammation, migraine, emesis and postherpetic neuralgia |
| 06/06/2000 | US6071898 Asiatic acid derivatives having modified A-ring |
| 06/06/2000 | US6071722 Nucleic acids encoding a G-protein coupled 7TM receptor (AXOR-1) |
| 06/06/2000 | US6071523 Oral administering from squeezable container; storage stability, heat resistance; drug delivery |
| 06/06/2000 | CA2198599C Salts of an anti-migraine indole derivative |
| 06/02/2000 | WO2000031280A2 Use of plus-strand synthesis elements in retroviral vectors |
| 06/02/2000 | WO2000031263A2 Gtpase associated proteins |
| 06/02/2000 | WO2000031244A1 Compositions comprising angiostatin and kringle 5 region of plasminogen and methods of use thereof |
| 06/02/2000 | WO2000031141A1 Humanized antibody specific for surface antigen pre-s1 of hbv and preparation method thereof |
| 06/02/2000 | WO2000031135A1 TGF$G(b)1 INHIBITOR PEPTIDES |
| 06/02/2000 | WO2000031129A1 Pharmaceutical compounds for the inhibition of hepatitis c virus ns3 protease |
| 06/02/2000 | WO2000031120A2 Hexapeptide with the stabilized disulfide bond and derivatives thereof regulating metabolism, proliferation, differentiation and apoptosis |
| 06/02/2000 | WO2000031109A1 USE OF CORE 2 GlcNAc TRANSFERASE INHIBITORS IN TREATING INFLAMMATION |
| 06/02/2000 | WO2000031084A1 Prostaglandin conjugates for treating or preventing bone disease |
| 06/02/2000 | WO2000031083A1 Phospholipid derivatives of non-steroidal anti-inflammatory drugs |
| 06/02/2000 | WO2000031073A1 Benzoxazole derivatives and drugs containing the same as the active ingredient |
| 06/02/2000 | WO2000031067A1 Propanoic acid derivatives as integrin inhibitors |
| 06/02/2000 | WO2000031065A1 Compounds having cytokine inhibitory activity |
| 06/02/2000 | WO2000031063A1 SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS |
| 06/02/2000 | WO2000031060A1 Scavenger compounds |
| 06/02/2000 | WO2000031055A1 Chrystals of 5-[{6-(2-fluorobenzyl)oxy-2-naphthyl}methyl]-2,4-thiazolidinedione |
| 06/02/2000 | WO2000031054A1 Il-5 inhibiting 6-azauracil derivatives |
| 06/02/2000 | WO2000031049A1 Quinoline and quinoxaline compounds as pdgf-r and/or lck tyrosine kinase inhibitors |
| 06/02/2000 | WO2000031047A1 Substituted 4-amino-2-aryl-cyclopenta[d]pyrimidines, their production and use and pharmaceuticalreparations containing same |
| 06/02/2000 | WO2000031038A1 Quinoline derivatives as nk-2 and nk-3 receptor ligands |
| 06/02/2000 | WO2000031037A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 06/02/2000 | WO2000030681A1 Antagonists of the alpha e beta 7 integrin as therapeutic agents for inflammatory diseases |
| 06/02/2000 | WO2000030650A1 Desmethylolanzapine compositions and methods |
| 06/02/2000 | WO2000030649A1 Pharmaceutical compositions containing olanzapine-n-oxide |
| 06/02/2000 | WO2000030640A1 Use of prucalopride for the manufacture of a medicament for the treatment of dyspepsia |